New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. - Wikidata - wikimedia - TriplyDB

New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.

New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.

http://www.wikidata.org/entity/Q38346526

about

Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site Pleiotropic effects of antithrombin strand 1C substitution mutations What do dysfunctional serpins tell us about molecular mobility and disease?Polysulfated trehalose as a novel anticoagulant agent with dual mode of action.Hemophilia A due to mutations that create new N-glycosylation sites.Cellular folding pathway of a metastable serpin.Albumin Redhill (-1 Arg, 320 Ala----Thr): a glycoprotein variant of human serum albumin whose precursor has an aberrant signal peptidase cleavage site.Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.Glycosaminoglycans and the regulation of blood coagulation.Carbohydrate isoforms of antithrombin variant N135Q with different heparin affinities.Expression and functional characterization of two natural heparin-binding site variants of antithrombin.Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F.

P2860

Q24557433-3E70F760-0FEA-4BA1-9C2D-5778D589315C Q24564590-5986937D-F2E8-4F50-A3BA-EDB21B5CE77F Q34058884-8D5E3BCA-3A45-4176-9744-67909C125681 Q35239901-33096F7D-E2C1-415E-8F27-DE6EE53E1681 Q37036321-624F6BBC-F38C-4C2F-8599-C13E803FE56D Q37183716-31D5F2A1-318D-473A-AEAA-6B99F70C52EF Q37655574-08C232E5-7903-44D2-83AB-6F273018D1A5 Q38326013-6C48AE80-3BA5-4D78-AF0A-6FF767E109EA Q40851193-A68536C1-570B-4D7D-938E-E69F017F9914 Q41513550-A2E2294B-9D90-4D21-81CF-527B6F74F2F9 Q48159506-CCA3D4DE-B878-48E2-B9CE-84D89B4F6FBB Q48178002-F2636DE6-BA88-431F-BACB-3AE7A3B2B9BF

P2860

New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity.

http://www.wikidata.org/entity/Q38346526

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

New carbohydrate site in mutan ...... th decreased heparin affinity.

@en

type

label

New carbohydrate site in mutan ...... th decreased heparin affinity.

@en

prefLabel

New carbohydrate site in mutan ...... th decreased heparin affinity.

@en

P1433

Q38346526-FF9C298F-F966-4071-A7D3-A5B466DB76E8

P1476

Q38346526-01261D29-EB16-4C9D-A7C7-935603BC078B

P2093

Q38346526-025BAF39-3234-4461-89F2-5445F2900B5B

Q38346526-4D0D2406-8C29-4E4E-AB9B-EAFF687FF823

Q38346526-4FCC2B52-298C-4776-A59E-1EE7FC56E7AB

Q38346526-9394D3E8-D2E7-420C-9A74-BF4FBBAA1489

Q38346526-997DFAA4-8383-48D4-8EA9-196E344EC1B2

Q38346526-D1C8F90C-C2C9-40AA-AD56-F472F3FF69BC

Q38346526-DAFE995D-8755-4C4A-9290-5289272F6FF3

P2860

Q38346526-4181B179-E4A9-4327-9A85-54C8AAA006C8

Q38346526-55588CC6-EF6D-4260-BAA9-7770B954B89B

Q38346526-63B99992-C511-44A6-B5CD-3520C6CE34E7

Q38346526-66768C6E-03DD-42BA-915E-0EAB3F98C8C0

Q38346526-AB2B8B6D-46F1-470B-9923-959F14525F3C

Q38346526-C2A7A0FF-9834-4188-81BD-AFD3361E7D91

Q38346526-D55F95B6-EBAC-406B-8252-E39C184EC1A3

P304

Q38346526-EC2C2D68-A131-422A-9AFD-DF737B2A5436

P31

Q38346526-EB3D39B2-3D18-41EE-A178-3555C6AF4402

P356

Q38346526-FEA06711-81C0-46DF-823C-EBD335195023

P407

Q38346526-E8F82FB5-4F4E-4AF0-AC51-2D9B4E6072BA

P433

Q38346526-5D2E51CC-0F59-4501-8777-64983F3C9188

P478

Q38346526-BE414E01-5B7E-4261-B3A9-49020A1B6E2F

P577

Q38346526-679CEE3A-395D-4565-8D9C-743DBC9030B1

P5875

Q38346526-737F1A80-478D-4128-B4A5-C2838539C02F

P698

Q38346526-93299D32-ADFE-498D-9C80-0CFD5415C081

P356

0014-5793(88)80183-2

P1433

P1476

New carbohydrate site in mutan ...... th decreased heparin affinity.

@en

P2093

Borg JY

http://www.w3.org/2001/XMLSchema#string

Brennan SO

http://www.w3.org/2001/XMLSchema#string

Caen J

http://www.w3.org/2001/XMLSchema#string

Carrell RW

http://www.w3.org/2001/XMLSchema#string

George PM

http://www.w3.org/2001/XMLSchema#string

Soria C

http://www.w3.org/2001/XMLSchema#string

Soria J

http://www.w3.org/2001/XMLSchema#string

P2860

Physiological variant of antithrombin-III lacks carbohydrate sidechain at Asn 135.

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.

Cleavage at cysteine after cyanylation.

Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.

Human plasma proteinase inhibitors.

A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.

The molecular abnormality of albumin Parklands: 365 Asp----His.

P304

118-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0014-5793(88)80183-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

237

http://www.w3.org/2001/XMLSchema#string

P577

1988-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19987526

http://www.w3.org/2001/XMLSchema#string

P698

3169232

http://www.w3.org/2001/XMLSchema#string